The demographics and baseline disease characteristics were well balanced between study arms. Table 12: Maintenance Therapy: Summary of Patient Characteristics in Study of NSCLC Patient characteristicALIMTA (N=441)Placebo (N=222) Age (yrs) Median (range ) 60.6 (25.6-82.6) 60.4 (35.4-78.5) Gender Male/Female 73.0%/27.0% 72.5%/27.5% Ethnic Origin Caucasian 279 (63.3%) 149 (67.1%) East Asian 104 (23.6%) 50 (22.5%)Protocol ADU-CL-02-v8Aduro Biotech, Inc. CRS-207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page 99Nonsquamous NSCLC Squamous Cell NSCLC 1.0 1.0 0.8 -AC 0.8 -AC :0 --Ge :0 --Ge (1S 0.6 (1S 0.6 .0 .0 0 e .... a.